NASDAQ:MCRB

1.17
0.02 (1.30%) 1d
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

The company Seres Therapeutics with symbol MCRB-Q has received a review indicating that it is poorly run and losing money hand over fist. This suggests that there may be internal management issues and financial instability within the company. This review highlights potential concerns for investors, and it may be wise to carefully consider the company's performance before making any investment decisions.

Consensus
Negative
Valuation
Undervalued
DON'T BUY
Seres Therapeutics

Poorly run, and it's losing money hand over fist.

biotechnology / pharmaceutical
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Seres Therapeutics(MCRB-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Seres Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Seres Therapeutics(MCRB-Q) Frequently Asked Questions

What is Seres Therapeutics stock symbol?

Seres Therapeutics is a American stock, trading under the symbol MCRB-Q on the NASDAQ (MCRB). It is usually referred to as NASDAQ:MCRB or MCRB-Q

Is Seres Therapeutics a buy or a sell?

In the last year, 1 stock analyst published opinions about MCRB-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Seres Therapeutics.

Is Seres Therapeutics a good investment or a top pick?

Seres Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Seres Therapeutics.

Why is Seres Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Seres Therapeutics worth watching?

In the last year 1 stock analyst on Stockchase covered Seres Therapeutics. The stock is worth watching.

What is Seres Therapeutics stock price?

On 2024-02-29, Seres Therapeutics (MCRB-Q) stock closed at a price of $1.165.